The Global Market for Intravascular Ultrasound (IVUS) is Forecast to Reach US$662.6 Million by 2020

Established Advantages Over Angiography to Drive Demand for IVUS Imaging, According to a New Report by Global Industry Analysts, Inc.

                                                                                                

GIA announces the release of a comprehensive global report on Intravascular Ultrasound (IVUS).

The global market for Intravascular Ultrasound (IVUS) is forecast to reach US$662.6 million by 2020, driven by the rising incidence of coronary artery diseases, and the technology’s demonstrated benefits over conventional angiography.

IVUS is an imaging technology that enables viewing of coronary and peripheral arteries by generating real-time, cross-sectional images. IVUS helps guide stent implantation and also provides superior visualization of in-vivo coronary plaque morphology. As an important intravascular imaging modality, IVUS is widely used in interventional cardiology, especially in percutaneous coronary intervention (PCI) procedures. The number of PCI procedures is therefore of critical importance to the growth of the IVUS market. Aging population, rising obesity rates, increasing prevalence of cardiovascular diseases such as coronary artery diseases are driving demand for intravascular ultrasound devices. Technological developments are paving the way for increased adoption of IVUS. One of the major factors fuelling growth is the emergence of robust data from large scale clinical trials such as PROSPECT and ADAPT-DES supporting the use of IVUS as an adjuvant tool in stenting and angiography procedures.

Being an expensive procedure, reimbursements remain critical to the adoption of IVUS procedures. Full reimbursement of IVUS procedures in Japan has enabled the country to emerge as one of the most important markets worldwide. The United States and Europe, meanwhile, do not reimburse IVUS procedures as payers see lack of comprehensive data supporting the technology’s effectiveness to justify its high costs. Unfavorable reimbursement policies for IVUS in other markets such as Asia and Latin America have resulted in significantly lower penetration over the years. Increasing competition from technologies such as Fractional Flow Reserve (FFR) and Optical Coherence Tomography (OCT) will continue to challenge growth in the market. In an effort to increase adoption, manufacturers are endeavoring to enhance the image resolution of IVUS systems. Integration of IVUS with other imaging modalities is gaining rapid interest. While the NIRS (near-infrared spectroscopy)-IVUS integrated system has already been launched, others such as intravascular photoacoustics and IVUS-OCT catheters are under development.

As stated by the new market research report on Intravascular Ultrasound (IVUS), the United States represents the largest market worldwide. Buoyed by favorable macroeconomic and demographic factors, emerging economies are expected to spearhead growth, with Asia-Pacific forecast to display the fastest CAGR of 11% over the analysis period.

Major players covered in the report include Volcano Corporation, Boston Scientific Corporation, Terumo Corporation, InfraReDx Inc. and Philips Healthcare.  

The research report titled “Intravascular Ultrasound (IVUS): A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides an in-depth review of market trends, drivers, issues, mergers, acquisitions and other strategic corporate activities of major companies worldwide. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World. Product markets analyzed in the report include IVUS Catheters and IVUS Consoles.